BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15902300)

  • 21. The relative activity of CXCR3 and CCR5 ligands in T lymphocyte migration: concordant and disparate activities in vitro and in vivo.
    Stanford MM; Issekutz TB
    J Leukoc Biol; 2003 Nov; 74(5):791-9. PubMed ID: 12960247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The viral KSHV chemokine vMIP-II inhibits the migration of Naive and activated human NK cells by antagonizing two distinct chemokine receptors.
    Yamin R; Kaynan NS; Glasner A; Vitenshtein A; Tsukerman P; Bauman Y; Ophir Y; Elias S; Bar-On Y; Gur C; Mandelboim O
    PLoS Pathog; 2013 Aug; 9(8):e1003568. PubMed ID: 23966863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells.
    Salcedo R; Resau JH; Halverson D; Hudson EA; Dambach M; Powell D; Wasserman K; Oppenheim JJ
    FASEB J; 2000 Oct; 14(13):2055-64. PubMed ID: 11023990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased natural killer (NK) cell function in chronic NK cell lymphocytosis associated with decreased surface expression of CD11b.
    Orange JS; Chehimi J; Ghavimi D; Campbell D; Sullivan KE
    Clin Immunol; 2001 Apr; 99(1):53-64. PubMed ID: 11286541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemokine receptor expression in cutaneous T cell and NK/T-cell lymphomas: immunohistochemical staining and in vitro chemotactic assay.
    Yagi H; Seo N; Ohshima A; Itoh T; Itoh N; Horibe T; Yoshinari Y; Takigawa M; Hashizume H
    Am J Surg Pathol; 2006 Sep; 30(9):1111-9. PubMed ID: 16931956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinction between T gamma lymphocytosis and other T-cell proliferations with monoclonal antibodies against T-cell and natural killer (NK) cell subsets.
    Van de Griend RJ; Ligthart GJ; Den Ottolander GJ; Bolhuis RL
    Neth J Med; 1985; 28(3):96-101. PubMed ID: 3872421
    [No Abstract]   [Full Text] [Related]  

  • 27. NK- and B-cell infiltration correlates with worse outcome in metastatic ovarian carcinoma.
    Dong HP; Elstrand MB; Holth A; Silins I; Berner A; Trope CG; Davidson B; Risberg B
    Am J Clin Pathol; 2006 Mar; 125(3):451-8. PubMed ID: 16613351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined low dose cyclosporine and prednisone down-regulate natural killer cell-like effector functions of CD8brightCD56+ T cells in patients with active Behçet uveitis.
    Ahn JK; Park YG; Park SW; Yoon KC; Yu HG; Chung H
    Ocul Immunol Inflamm; 2006 Oct; 14(5):267-75. PubMed ID: 17056460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ccr5 deficiency regulates the proliferation and trafficking of natural killer cells under physiological conditions.
    Weiss ID; Shoham H; Wald O; Wald H; Beider K; Abraham M; Barashi N; Galun E; Nagler A; Peled A
    Cytokine; 2011 Jun; 54(3):249-57. PubMed ID: 21376626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A phenotypic and functional characterization of NK cells in adenoids.
    Mizrahi S; Yefenof E; Gross M; Attal P; Ben Yaakov A; Goldman-Wohl D; Maly B; Stern N; Katz G; Gazit R; Sionov RV; Mandelboim O; Chaushu S
    J Leukoc Biol; 2007 Nov; 82(5):1095-105. PubMed ID: 17675561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Two patients with chronic lymphocytosis of large granular lymphocytes; benign or premalignant?].
    Hoffmann JJ; Breed WP
    Ned Tijdschr Geneeskd; 2000 Jul; 144(27):1323-7. PubMed ID: 10918913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Aggressive natural killer cell leukemia/lymphoma--possible existence of a new clinical entity originating from the third lineage of lymphoid cells].
    Imamura N; Kusunoki Y; Oda K; Abe K; Dohi H; Inada T; Kuramoto A; Kajihara H; Fujii H; Kawa K
    Rinsho Ketsueki; 1989 Feb; 30(2):193-201. PubMed ID: 2664262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of chemokine receptors expressed in primitive blood cells during human hematopoietic ontogeny.
    Rosu-Myles M; Khandaker M; Wu DM; Keeney M; Foley SR; Howson-Jan K; Yee IC; Fellows F; Kelvin D; Bhatia M
    Stem Cells; 2000; 18(5):374-81. PubMed ID: 11007922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In situ leukemic plasmacytoid dendritic cells pattern of chemokine receptors expression and in vitro migratory response.
    Bendriss-Vermare N; Chaperot L; Peoc'h M; Vanbervliet B; Jacob MC; Briere F; Bensa JC; Caux C; Plumas J
    Leukemia; 2004 Sep; 18(9):1491-8. PubMed ID: 15284853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Roles of chemokines and receptor polarization in NK-target cell interactions.
    Nieto M; Navarro F; Perez-Villar JJ; del Pozo MA; González-Amaro R; Mellado M; Frade JM; Martínez-A C; López-Botet M; Sánchez-Madrid F
    J Immunol; 1998 Oct; 161(7):3330-9. PubMed ID: 9759849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. State of the art in natural killer cell malignancies.
    Semenzato G; Marino F; Zambello R
    Int J Lab Hematol; 2012 Apr; 34(2):117-28. PubMed ID: 21895989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.
    Berghuis D; Santos SJ; Baelde HJ; Taminiau AH; Egeler RM; Schilham MW; Hogendoorn PC; Lankester AC
    J Pathol; 2011 Feb; 223(3):347-57. PubMed ID: 21171080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression levels of CXC chemokine receptors 3 are associated with clinical phenotype of type 1 diabetes.
    Yamada S; Oikawa Y; Sakai G; Atsumi Y; Maruyama T; Shimada A
    Ann N Y Acad Sci; 2006 Oct; 1079():186-9. PubMed ID: 17130553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Scleritis and multiple systemic autoimmune manifestations in chronic natural killer cell lymphocytosis associated with elevated TCRalpha/beta+CD3+CD4-CD8- double-negative T cells.
    Yeh S; Li Z; Sen HN; Lim WK; Gill F; Perkins K; Rao VK; Nussenblatt RB
    Br J Ophthalmol; 2010 Jun; 94(6):748-52. PubMed ID: 20508050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural killer cell alterations correlate with loss of renal function and dialysis duration in uraemic patients.
    Vacher-Coponat H; Brunet C; Lyonnet L; Bonnet E; Loundou A; Sampol J; Moal V; Dussol B; Brunet P; Berland Y; Dignat-George F; Paul P
    Nephrol Dial Transplant; 2008 Apr; 23(4):1406-14. PubMed ID: 18029366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.